Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Opioids Stories

2012-02-28 14:58:52

Housing coupled with day treatment increases chances of abstinence at 6 months New Johns Hopkins research suggests that providing housing contingent on drug abstinence to inner-city opioid abusers leaving a detoxification program significantly increases their chances of remaining drug-free six months later. Relapse rates for people leaving detox range from 65 to 80 percent one month after discharge, according to a report by the researchers published in the journal Addiction. But,...

2012-02-28 14:57:33

Opioid-dependent individuals who want to kick the habit typically begin the road to recovery with detoxification. But detox is ineffective as a stand-alone treatment, with relapse rates ranging from 65% to 80% just one month after discharge. New research published online today in the journal Addiction reveals that individuals with substance use disorders may be as much as ten times more likely to stay abstinent when they have access to drug-free recovery housing and day-treatment programs...

2012-02-28 09:40:46

A new report from researchers at the Drexel University School of Public Health identifies patterns in the misuse of illicit drugs among young adults  who also misuse prescription drugs.  The report, “Misuse of Prescription and Illicit Drugs among High-Risk Adults” in Los Angeles and New York, was recently published in the first issue of the Journal of Public Health Research. This is the first report to compare patterns of prescription and illicit drug misuse among...

2012-02-28 06:00:00

RALEIGH, N.C., Feb. 28, 2012 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) on the development program for BEMA Buprenorphine/Naloxone (BNX) that should result in a New Drug Application (NDA) filing for the treatment of opioid dependence in the first half of 2013. BDSI recently met with the FDA and discussed the results of its recently completed pharmacokinetic study...

2012-02-27 07:30:00

SAN FRANCISCO, Feb. 27, 2012 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced a presentation of positive clinical data for NKTR-181, its new oral opioid analgesic molecule, at the 2012 American Academy of Pain Medicine's 28th Annual Meeting (AAPM). NKTR-181 is a novel mu-opioid agonist molecule, which was designed to have a slow rate of entry into the brain to reduce the attractiveness of the molecule as a target of abuse and to reduce its CNS-mediated side effects....

2012-02-27 07:00:00

BALTIMORE, Feb. 27, 2012 /PRNewswire/ -- Ameritox(SM), the nation's leader in pain medication monitoring, commends the expert authors of "Recommendations For Urine Drug Monitoring For Patients On Long-Term Opioid Therapy," unveiled Friday evening in a poster session at the American Academy of Pain Medicine's (AAPM) 28th Annual Meeting in Palm Springs, California. The expert consensus recommendations seek to answer key questions that physicians may have about medication monitoring for...

2012-02-24 17:30:00

PALM SPRINGS, Calif., Feb. 24, 2012 /PRNewswire-USNewswire/ -- Results were presented today from the first study to show that the daily use of long-acting opioids increases the risk of hypogonadism (low testosterone) in men when compared to those taking short-acting opioids. These results were reported today at a poster session at the American Academy of Pain Medicine's 28th Annual Meeting. Although this was a small retrospective study, Dr. Rubinstein believes this higher rate of...

2012-02-24 13:00:00

PALM SPRINGS, Calif., Feb. 24, 2012 /PRNewswire-USNewswire/ -- Research presented today at the American Academy of Pain Medicine's 28th Annual Meeting shows that substance use education incorporated into a cognitive behavioral rehabilitation programming is effective to improve pain and function for the chronic pain patient at high-risk for comorbid substance abuse. The results of the study conducted at Mayo Pain Rehabilitation Center, Rochester, MN, were presented today by Sarah E. Hayes...

2012-02-24 08:00:00

CUPERTINO, Calif., Feb. 24, 2012 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) fourth quarter 2011 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Thursday, March 1, 2012 at 4:30 pm Eastern Time (1:30 pm Pacific Time). (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) A live audio webcast of the presentation will be available by accessing DURECT's homepage at...

2012-02-23 17:19:00

BALTIMORE, Feb. 23, 2012 /PRNewswire/ -- Event details: February 25, 2012 12 p.m. - 1:15 p.m. Renaissance Palm Springs Hotel Catalina/Madera Room Palm Springs, CA Ameritox(SM), the nation's leader in pain medication monitoring, will sponsor a safe opioid prescribing symposium highlighting emerging trends and technologies in medication monitoring at the American Academy of Pain Medicine's (AAPM) 28th Annual Meeting in Palm Springs, California. "For clinicians treating the...